GGTLC1 and type 2 diabetes mellitus: Studies have proved that among the most studied clinical liver serum bio-markers(AST, ALT, gamma-glutamyl transpeptidase, alkaline phosphatase), higher serum AST or ALT is associated with higher T2DM risk [15–17].